HRMY logo

Harmony Biosciences Holdings, Inc. (HRMY)

Profile

Full Name

Harmony Biosciences Holdings, Inc.

Ticker

NASDAQ: HRMY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 19, 2020

Indexes

Not included

Website

https://www.harmonybiosciences.com

Employees

268

Key Details

Price

$34.40(-2.22%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$714.73M(+22.80% YoY)

Annual EPS

$2.51(+17.84% YoY)

PE ratio

13.13

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $34.40
    HRMY price is $34.40

    30-Day Relative Volume

    1.16
    HRMY 30-day relative volume is 1.16

    Price Performance

    Price Most recent change

    -2.22%
    HRMY price was down -2.22% on Aug 1, 2025

    Price YTD change

    -0.03%
    HRMY price is down -0.03% since January 1st

    Price 1-year change

    +5.13%
    HRMY price is up +5.13% year-on-year

    Price 3-year change

    -30.12%
    HRMY price is down -30.12% over the past 3 years

    Price Range

    Price All-time high

    $62.09
    HRMY price is currently -44.59% below its historical high of $62.09

    Price 3-year low

    $18.61
    HRMY price is currently +84.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.98B
    HRMY market capitalization is $1.98 billion

    Market cap 3-year change

    -32.18%
    HRMY market capitalization is down -32.18% over the past 3 years

    Market cap All-time high

    $3.62B
    HRMY market capitalization is currently -45.41% below its historical high of $3.62 billion

    Market cap sector rank

    82.33%
    HRMY market capitalization is higher than 82.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.04%
    HRMY shares outstanding is up +1.04% year-on-year

    Shares Outstanding 3-Year Change

    -2.94%
    HRMY shares outstanding is down -2.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    HRMY beta is 0.66

    200-day SMA

    $34.14
    HRMY price is currently +0.76% above its 200-day simple moving average

    50-day SMA

    $34.18
    HRMY price is currently +0.65% above its 50-day simple moving average

    RSI

    47.08
    HRMY 14-day relative strength index is 47.08

    Volume

    1.16
    HRMY 30-day relative volume is 1.16

    ATR

    $1.23
    HRMY average true range is $1.23

    10-day Historical Volatility

    38.73%
    HRMY 10-day historical volatility is 38.73%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $714.73M
    HRMY annual revenue is $714.73 million

    Revenue Analysts estimate

    $843.63M
    HRMY annual revenue is currently -15.28% lower than the consensus analysts' forecast

    Revenue 1-year change

    +22.8%
    HRMY annual revenue is up +22.8% year-on-year

    Revenue Sector rank

    77.46%
    HRMY annual revenue is higher than 77.46% of companies in Healthcare sector

    EPS

    EPS

    $2.51
    HRMY annual earnings per share is $2.51

    EPS Analysts estimate

    $4.06
    HRMY annual earnings per share is currently -38.16% lower than the consensus analysts' forecast

    EPS 1-year change

    +17.84%
    HRMY annual earnings per share is up +17.84% year-on-year

    EPS Sector rank

    93.09%
    HRMY annual earnings per share is higher than 93.09% of companies in Healthcare sector

    Profit

    Gross profit

    $557.92M
    HRMY annual gross profit is $557.92 million

    Gross margin

    78.06%
    HRMY annual gross profit margin is 78.06%

    Operating profit

    $190.83M
    HRMY annual operating income is $190.83 million

    Operating margin

    26.70%
    HRMY annual operating profit margin is 26.70%

    Net income

    $145.49M
    HRMY annual net profit is $145.49 million

    Net margin

    20.36%
    HRMY annual net profit margin is 20.36%

    Expenses

    Total expenses

    $523.91M
    HRMY annual total expenses is $523.91 million

    Operating expenses

    $367.09M
    HRMY annual total operating expenses is $367.09 million

    Cost of goods sold

    $156.81M
    HRMY annual cost of goods sold is $156.81 million

    Selling, general & administrative expenses

    $221.27M
    HRMY annual SGA is $221.27 million

    Depreciation and amortization

    $24.11M
    HRMY annual depreciation & amortization is $24.11 million

    Interest expense

    $17.50M
    HRMY annual interest expense is $17.50 million

    Income tax

    $46.31M
    HRMY annual income tax is $46.31 million

    EBIT & EBITDA

    EBIT

    $209.30M
    HRMY annual earnings before interest & taxes is $209.30 million

    EBITDA

    $233.41M
    HRMY annual EBITDA is $233.41 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $999.20M
    HRMY annual total assets is $999.20 million

    Non current assets

    $419.95M
    HRMY annual long term assets is $419.95 million

    Current assets

    $579.25M
    HRMY annual total current assets is $579.25 million

    Cash and cash equivalents

    $453.00M
    HRMY annual cash & cash equivalents is $453.00 million

    Accounts receivable

    $83.03M
    HRMY annual accounts receivable is $83.03 million

    Inventory

    $7.20M
    HRMY annual inventory is $7.20 million

    Liabilities

    Total liabilities

    $340.05M
    HRMY annual total liabilities is $340.05 million

    Long term liabilities

    $164.96M
    HRMY annual total long term liabilities is $164.96 million

    Current liabilities

    $175.08M
    HRMY annual total current liabilities is $175.08 million

    Accounts payable

    $13.74M
    HRMY annual accounts payable is $13.74 million

    Debt

    Total debt

    $179.27M
    HRMY annual total debt is $179.27 million

    Total debt 1-year change

    -7.39%
    HRMY annual total debt is down -7.39% year-on-year

    Long term debt

    $163.02M
    HRMY annual long term debt is $163.02 million

    Short term debt

    $16.25M
    HRMY annual short term debt is $16.25 million

    Equity & Capital

    Shareholders equity

    $659.15M
    HRMY annual stockholders equity is $659.15 million

    Book value

    $659.15M
    HRMY annual book value is $659.15 million

    Retained earnings

    $2.22M
    HRMY annual retained earnings is $2.22 million

    Working capital

    $404.17M
    HRMY annual working capital is $404.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $219.82M
    HRMY annual cash flow from operations is $219.82 million

    Cash from operations 1-year change

    +0.2%
    HRMY annual cash flow from operations is up +0.2% year-on-year

    Cash from investing

    -$67.48M
    HRMY annual cash flow from investing activities is -$67.48 million

    Cash from investing 1-year change

    -45.32%
    HRMY annual cash flow from investing activities is down -45.32% year-on-year

    Cash from financing

    -$11.00M
    HRMY annual cash flow from financing activities is -$11.00 million

    Cash from financing 1-year change

    +89.58%
    HRMY annual cash flow from financing activities is up +89.58% year-on-year

    CAPEX

    CAPEX

    $1.15M
    HRMY annual capital expenditures is $1.15 million

    CAPEX 1-year change

    +269.55%
    HRMY annual capital expenditures is up +269.55% year-on-year

    Free Cash Flow

    Free cash flow

    $218.67M
    HRMY annual free cash flow is $218.67 million

    Free cash flow 1-year change

    -0.19%
    HRMY annual free cash flow is down -0.19% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    78.06%
    HRMY annual gross profit margin is 78.06%

    Operating margin

    26.70%
    HRMY annual operating profit margin is 26.70%

    Net margin

    20.36%
    HRMY annual net profit margin is 20.36%

    ROA & ROE

    ROA

    16.07%
    HRMY annual return on assets is 16.07%

    ROE

    25.84%
    HRMY annual return on equity is 25.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    13.13
    HRMY price to earnings ratio is 13.13

    PE ratio Sector rank

    23.85%
    HRMY price to earnings ratio is higher than 23.85% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.74
    HRMY price to book ratio is 2.74

    PB ratio Sector rank

    65.64%
    HRMY price to book ratio is higher than 65.64% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.65
    HRMY price to sales ratio is 2.65

    PS ratio Sector rank

    47.2%
    HRMY price to sales ratio is higher than 47.2% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.66B
    HRMY enterprise value is $1.66 billion

    Enterprise value Sector rank

    79.25%
    HRMY enterprise value is higher than 79.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    6.99
    HRMY EV/EBITDA is 6.99

    EV/EBITDA Sector rank

    79.58%
    HRMY EV/EBITDA is higher than 79.58% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.31
    HRMY annual current ratio is 3.31

    Quick ratio

    3.27
    HRMY annual quick ratio is 3.27

    Leverage

    Debt to equity

    0.27
    HRMY annual debt to equity ratio is 0.27

    Interest coverage ratio

    11.96
    HRMY annual interest coverage ratio is 11.96

    Risk & Stability

    Piotroski F-Score

    8
    HRMY piotroski f-score is 8

    Altman Z-Score

    5.38
    HRMY altman z-score is 5.38

    Analyst ratings

    Recent major analysts updates

    Jul 21, 25 Truist Securities
    Buy
    Jul 10, 25 Deutsche Bank
    Buy
    May 15, 25 Mizuho
    Outperform
    May 7, 25 Needham
    Buy
    May 6, 25 Needham
    Buy
    Apr 28, 25 UBS
    Buy
    Apr 10, 25 Needham
    Buy
    Apr 8, 25 Needham
    Buy
    Apr 8, 25 HC Wainwright & Co.
    Buy
    Mar 18, 25 Mizuho
    Outperform

    Institutional Ownership

    Screeners with HRMY included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Harmony Biosciences Holdings, Inc.?
    • Does Harmony Biosciences Holdings, Inc. pay dividends?
    • What sector is Harmony Biosciences Holdings, Inc. in?
    • What industry is Harmony Biosciences Holdings, Inc. in?
    • What country is Harmony Biosciences Holdings, Inc. based in?
    • When did Harmony Biosciences Holdings, Inc. go public?
    • Is Harmony Biosciences Holdings, Inc. in the S&P 500?
    • Is Harmony Biosciences Holdings, Inc. in the NASDAQ 100?
    • Is Harmony Biosciences Holdings, Inc. in the Dow Jones?
    • When was Harmony Biosciences Holdings, Inc.'s last earnings report?
    • When does Harmony Biosciences Holdings, Inc. report earnings?

    What is the ticker symbol for Harmony Biosciences Holdings, Inc.?

    The ticker symbol for Harmony Biosciences Holdings, Inc. is NASDAQ:HRMY

    Does Harmony Biosciences Holdings, Inc. pay dividends?

    No, Harmony Biosciences Holdings, Inc. does not pay dividends

    What sector is Harmony Biosciences Holdings, Inc. in?

    Harmony Biosciences Holdings, Inc. is in the Healthcare sector

    What industry is Harmony Biosciences Holdings, Inc. in?

    Harmony Biosciences Holdings, Inc. is in the Biotechnology industry

    What country is Harmony Biosciences Holdings, Inc. based in?

    Harmony Biosciences Holdings, Inc. is headquartered in United States

    When did Harmony Biosciences Holdings, Inc. go public?

    Harmony Biosciences Holdings, Inc.'s initial public offering (IPO) was on August 19, 2020

    Is Harmony Biosciences Holdings, Inc. in the S&P 500?

    No, Harmony Biosciences Holdings, Inc. is not included in the S&P 500 index

    Is Harmony Biosciences Holdings, Inc. in the NASDAQ 100?

    No, Harmony Biosciences Holdings, Inc. is not included in the NASDAQ 100 index

    Is Harmony Biosciences Holdings, Inc. in the Dow Jones?

    No, Harmony Biosciences Holdings, Inc. is not included in the Dow Jones index

    When was Harmony Biosciences Holdings, Inc.'s last earnings report?

    Harmony Biosciences Holdings, Inc.'s most recent earnings report was on May 6, 2025

    When does Harmony Biosciences Holdings, Inc. report earnings?

    The next expected earnings date for Harmony Biosciences Holdings, Inc. is August 5, 2025
    On this page